Stable siRNA-mediated silencing of ATM alters the transcriptional profile of HeLa cells

Biochemical and Biophysical Research Communications

Volumn 317, Issue 4, 2004, Pages 1037-1044

  Chen, Shujuan ^a   Wang, Gang ^a   Makrigiorgos, G Mike ^a   Price, Brendan D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Ataxia Telangiectasia; ATM; Interferon; Radiosensitivity; siRNA

Indexed keywords

ATM PROTEIN; INTERFERON; MEMBRANE PROTEIN; PLASMID VECTOR; REGULATOR PROTEIN; SCLEROPROTEIN; SMALL INTERFERING RNA;

ARTICLE; CELL CYCLE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE SILENCING; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; IONIZING RADIATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

CELL CYCLE PROTEINS; CELL SURVIVAL; DNA-BINDING PROTEINS; FLUORESCENCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; HELA CELLS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN-SERINE-THREONINE KINASES; RADIATION, IONIZING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 1942516375     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.03.149     Document Type: Article

References (41)

1. Cline S.D., Hanawalt P.C. Who's on first in the cellular response to DNA damage? Nat. Rev. Mol. Cell Biol. 4:2003;361-372.
2. Bradbury J.M., Jackson S.P. ATM and ATR. Curr. Biol. 13:2003;R468.
3. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer. 3:2003;155-168.
4. Lavin M.F., Shiloh Y. The genetic defect in ataxia-telangiectasia. Annu. Rev. Immunol. 15:1997;177-202.
5. Keating K.E., Gueven N., Watters D., Rodemann H.P., Lavin M.F. Transcriptional downregulation of ATM by EGF is defective in ataxia-telangiectasia cells expressing mutant protein. Oncogene. 20:2001;4281-4290.
6. Peretz S., Jensen R., Baserga R., Glazer P.M. ATM-dependent expression of the insulin-like growth factor-I receptor in a pathway regulating radiation response. Proc. Natl. Acad. Sci. USA. 98:2001;1676-1681.
7. R. Sedgewick, E. Boder, in: P.J. Vinken, G.W. Bruyn, H.L. Klavans (Eds.), Handbook of Clinical Neurology, Elsevier, Amstersdam, 1991, vol. 61, pp. 347-423
8. Jung M., Zhang Y., Lee S., Dritschilo A. Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated I kappa B-alpha. Science. 268:1995;1619-1621.
9. Weizman N., Shiloh Y., Barzilai A. Contribution of the Atm protein to maintaining cellular homeostasis evidenced by continuous activation of the AP-1 pathway in Atm-deficient brains. J. Biol. Chem. 278:2003;6741-6747.
10. Gatei M., Shkedy D., Khanna K.K., Uziel T., Shiloh Y., Pandita T.K., Lavin M.F., Rotman G. Ataxia-telangiectasia: chronic activation of damage-responsive functions is reduced by alpha-lipoic acid. Oncogene. 20:2001;289-294.
11. Varghese S., Jung M. Overexpression of Rb and E2F-1 in ataxia-telangiectasia lymphocytes. Arch. Pharm. Res. 21:1998;640-644.
12. Turenne G.A., Paul P., Laflair L., Price B.D. Activation of p53 transcriptional activity requires ATM's kinase domain and multiple N-terminal serine residues of p53. Oncogene. 20:2001;5100-5110.
13. Chen S., Paul P., Price B.D. ATM's leucine-rich domain and adjacent sequences are essential for ATM to regulate the DNA damage response. Oncogene. 22:2003;6332-6339.
14. Makrigiorgos G.M., Chakrabarti S., Zhang Y., Kaur M., Price B.D. A PCR-based amplification method retaining the quantitative difference between two complex genomes. Nat. Biotechnol. 20:2002;936-939.
15. Li C., Wong W.H. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. USA. 98:2001;31-36.
16. ′ exonuclease activity of Thermus aquaticus DNA polymerase Proc. Natl. Acad. Sci. USA. 88:1991;7276-7280.
17. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res. 6:1996;986-994.
18. Sui G., Soohoo C., Affar el B., Gay F., Shi Y., Forrester W.C. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA. 99:2002;5515-5520.
19. Taylor A.M., Harnden D.G., Arlett C.F., Harcourt S.A., Lehmann A.R., Stevens S., Bridges B.A. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature. 258:1975;427-429.
20. Arlett C.F., Green M.H., Priestley A., Harcourt S.A., Mayne L.V. Comparative human cellular radiosensitivity: I. The effect of SV40 transformation and immortalisation on the gamma-irradiation survival of skin derived fibroblasts from normal individuals and from ataxia-telangiectasia patients and heterozygotes. Int. J. Radiat. Biol. 54:1988;911-928.
21. Beamish H., Lavin M.F. Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cell cycle delay. Int. J. Radiat. Biol. 65:1994;175-184.
22. Lipshutz R.J., Fodor S.P., Gingeras T.R., Lockhart D.J. High density synthetic oligonucleotide arrays. Nat. Genet. 21:1999;20-24.
23. ′ -oligo (A) polymerase and protein kinase of interferon-treated HeLa cells J. Biol. Chem. 254:1979;10180-10183.
24. Bridge A.J., Pebernard S., Ducraux A., Nicoulaz A.L., Iggo R. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34:2003;263-264.
25. Sledz C.A., Holko M., de Veer M.J., Silverman R.H., Williams B.R. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5:2003;834-839.
26. Chi J.T., Chang H.Y., Wang N.N., Chang D.S., Dunphy N., Brown P.O. Genomewide view of gene silencing by small interfering RNAs. Proc. Natl. Acad. Sci. USA. 100:2003;6343-6346.
27. Jackson A.L., Bartz S.R., Schelter J., Kobayashi S.V., Burchard J., Mao M., Li B., Cavet G., Linsley P.S. Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21:2003;635-637.
28. Semizarov D., Frost L., Sarthy A., Kroeger P., Halbert D.N., Fesik S.W. Specificity of short interfering RNA determined through gene expression signatures. Proc. Natl. Acad. Sci. USA. 100:2003;6347-6352.
29. Nicchia G.P., Frigeri A., Liuzzi G.M., Svelto M. Inhibition of aquaporin-4 expression in astrocytes by RNAi determines alteration in cell morphology, growth, and water transport and induces changes in ischemia-related genes. FASEB J. 17:2003;1508-1510.
30. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14:2001;778-809. table of contents.
31. Williams B.R. PKR: a sentinel kinase for cellular stress. Oncogene. 18:1999;6112-6120.
32. Siddoo-Atwal C., Haas A.L., Rosin M.P. Elevation of interferon beta-inducible proteins in ataxia telangiectasia cells. Cancer Res. 56:1996;443-447.
33. Pamment J., Ramsay E., Kelleher M., Dornan D., Ball K.L. Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway. Oncogene. 21:2002;7776-7785.
34. Kim T., Kim T.Y., Song Y.H., Min I.M., Yim J., Kim T.K. Activation of interferon regulatory factor 3 in response to DNA-damaging agents. J. Biol. Chem. 274:1999;30686-30689.
35. Khodarev N.N., Beckett M., Labay E., Darga T., Roizman B., Weichselbaum R.R. STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc. Natl. Acad. Sci. USA. 101:2004;1714-1719.
36. Khanna K.K., Beamish H., Yan J., Hobson K., Williams R., Dunn I., Lavin M.F. Nature of G1/S cell cycle checkpoint defect in ataxia-telangiectasia. Oncogene. 11:1995;609-618.
37. Barlow C., Dennery P.A., Shigenaga M.K., Smith M.A., Morrow J.D., Roberts 2nd L.J., Wynshaw-Boris A., Levine R.L. Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc. Natl. Acad. Sci. USA. 96:1999;9915-9919.
38. Barzilai A., Rotman G., Shiloh Y. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair (Amst.). 1:2002;3-25.
39. Anderson J.L., Head S.I., Rae C., Morley J.W. Brain function in Duchenne muscular dystrophy. Brain. 125:2002;4-13.
40. Holder E., Maeda M., Bies R.D. Expression and regulation of the dystrophin Purkinje promoter in human skeletal muscle, heart, and brain. Hum. Genet. 97:1996;232-239.
41. Meyn M.S. Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene. Clin. Genet. 55:1999;289-304.